DiaMedica Therapeutics Inc.
DMAC | NASDAQ
$7.39
+$0.13 (+1.79%)
Sep 22, 2026, 12:43 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -37.54M | -35.1M | -32.77M | -31.93M | -29.58M | -27M | -24.44M | -21.71M | -19.9M | -19.26M | -19.38M | -17.97M | -16.56M | -15.44M | -13.68M | -13.17M | -13.56M | -13.48M | -13.59M | -14.55M | -14.29M | -13.49M |
Depreciation & Amortization | 61K | 52K | 52K | 43K | 35K | 42K | 39K | 36K | 34K | 31K | 30K | 28K | 27K | 26K | 25K | 25K | 24K | 24K | 24K | 23K | 22K | 21K |
Stock-Based Compensation | 3.13M | 2.79M | 2.83M | 2.23M | 2.79M | 2.46M | 2.09M | 1.95M | 1.81M | 1.75M | 1.68M | 1.64M | 1.63M | 1.62M | 1.5M | 1.39M | 1.27M | 1.36M | 1.56M | 1.77M | 1.97M | 1.96M |
Other Working Capital | 1.15M | -675.29K | 175.71K | 1.08M | 1.43M | 2.18M | 1.37M | 1.24M | -59K | -130K | 188K | -225K | 59K | -22K | 392K | -196K | -547K | 45K | -81K | -44K | 430K | 5K |
Other Non-Cash Items | 157.11K | 144.11K | 71.11K | 106 | -1.06M | -1.2M | -1.27M | -1.31M | -1.37M | -1.28M | -1.15M | -916K | -536K | -270K | 53K | 290K | 344K | 314K | 219K | 127K | 111K | 89K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.63M | 1.07M | 696.03K | 1.87M | 2.16M | 3.12M | 1.51M | 1.57M | -359K | -1.54M | 93K | -461K | 191K | 1.36M | 585K | -82K | -314K | -42K | -461K | 166K | 420K | 898K |
Operating Cash Flow | -31.57M | -31.05M | -29.12M | -27.79M | -25.65M | -22.57M | -22.08M | -19.45M | -19.78M | -20.29M | -18.73M | -17.68M | -15.25M | -12.71M | -11.51M | -11.55M | -12.23M | -11.83M | -12.25M | -12.46M | -11.77M | -10.52M |
Capital Expenditures | -33.19K | -36.19K | -40.19K | -41.19K | -34K | -28K | -25K | -21K | -22K | -26K | -24K | -53K | -86K | -88K | -81K | -56K | -15K | -13K | -22K | -60K | -58K | -54K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53K | -2.53K | -2.53K | -2.53K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -67.04M | -71.79M | -59.76M | -62.49M | -48.73M | -47.49M | -50.41M | -44.5M | -34.71M | -69.37M | -69.41M | -74.33M | -70.92M | -42.13M | -45.68M | -57.97M | -72.08M | -71.27M | -69.81M | -62.44M | -56.19M | -42.87M |
Sales Maturities Of Investments | 54.99M | 60.46M | 57.17M | 57.11M | 63.97M | 58.5M | 59M | 54M | 51M | 52.8M | 51.14M | 54.68M | 52.18M | 54.05M | 57.3M | 56.15M | 55.32M | 52.97M | 49.3M | 51.3M | 43.88M | 32.06M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.53K | 2.53K | 2.53K | 2.53K | n/a | 2K | 18K | 18K | 18K |
Investing Cash Flow | -12.08M | -11.37M | -2.63M | -5.42M | 15.2M | 10.98M | 8.56M | 9.48M | 16.26M | -16.6M | -18.3M | -19.7M | -18.82M | 11.83M | 11.54M | -1.88M | -16.78M | -18.31M | -20.54M | -11.18M | -12.35M | -10.84M |
Debt Repayment | -11.03K | -10.03K | -10.03K | -11.03K | -11K | -11K | -9K | -7K | -6K | -6K | -6K | -6K | -6K | -5.99K | -5.99K | -5.99K | -5.99K | -5K | -6K | -6K | -5K | -5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.75K | 158.25K | 252.25K | -82.94K | 506K | 12.1M | 12M | 11.88M | 11.75M | 36.85M | 36.85M | 36.85M | 36.85M | -12.09 | -12.09 | -12.09 | -12.09 | n/a | 244K | 273K | 273K | 273K |
Financial Cash Flow | 44.65M | 44.68M | 44.36M | 32.38M | 495K | 12.09M | 11.99M | 11.87M | 11.74M | 36.84M | 36.84M | 36.84M | 36.85M | -6K | -6K | -24K | 29.84M | 29.84M | 30.09M | 30.07M | 21.39M | 21.39M |
Net Cash Flow | 1.02M | 2.28M | 12.62M | -808K | -9.96M | 492K | -1.52M | 1.9M | 8.23M | -50K | -185K | -539K | 2.78M | -885K | 21K | -13.45M | 834K | -297K | -2.7M | 6.42M | -2.73M | 29K |
Free Cash Flow | -31.6M | -31.09M | -29.16M | -27.83M | -25.69M | -22.6M | -22.1M | -19.48M | -19.8M | -20.32M | -18.75M | -17.74M | -15.33M | -12.8M | -11.59M | -11.61M | -12.25M | -11.84M | -12.27M | -12.52M | -11.82M | -10.57M |
Adj. Free Cash Flow | -34.73M | -33.87M | -31.99M | -30.05M | -28.48M | -25.06M | -24.19M | -21.43M | -21.62M | -22.07M | -20.44M | -19.37M | -16.96M | -14.42M | -13.09M | -12.99M | -13.52M | -13.2M | -13.83M | -14.29M | -13.79M | -12.54M |
Maintenance CapEx | -33.19K | -33.19K | -36.19K | -37.19K | -30K | -27K | -25K | -21K | -22K | -26K | -24K | -53K | -86K | -88K | -81K | -56K | -15K | -13K | -22K | -60K | -58K | -54K |
Growth CapEx | n/a | -3K | -4K | -4K | -4K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -31.6M | -31.08M | -29.15M | -27.82M | -25.68M | -22.6M | -22.1M | -19.48M | -19.8M | -20.32M | -18.75M | -17.74M | -15.33M | -12.8M | -11.59M | -11.61M | -12.25M | -11.84M | -12.27M | -12.52M | -11.82M | -10.57M |
Add to Watchlist
Select watchlists to add or remove DMAC